Addressing health disparities in diabetes requires a broader look at systemic racism

January 26, 2021

WASHINGTON--Poor social conditions caused by systemic racism contribute to health disparities in people with diabetes, according to a paper published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Minorities are disproportionately affected by diabetes because of poor social conditions that contribute to negative health outcomes such as poverty, unsafe housing, lack of access to healthy food and safe physical activity, and inadequate employment and educational opportunities. These are known as the social determinants of health and are the result of residential racial segregation and a lack of economic investment in Black communities. Unethical practices and experimentation in minority communities have also caused racial bias in our medical systems and a lack of trust between minority patients and health care providers.

"Traditionally, physicians have focused on the biological contributors to disparities in diabetes, obesity and other chronic diseases; however, given the bright light shone on health disparities during the COVID-19 pandemic, we need to view the contributing factors and solutions more broadly," said study author Sherita Golden, M.D., M.H.S., of Johns Hopkins Medicine in Baltimore, Md. "This will give us agency in contributing to and advocating for health system, public health and policy-level interventions to address the structural and institutional racism embedded in our medical and social systems."

To address health disparities in diabetes, the authors recommend health systems implement the National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care. These standards ensure interpretation services are available to all patients and that patient education materials are at a literacy level most people can understand. They also recommend more training among health care providers on unconscious bias, anti-racism, and the value of diversity in clinical care settings.
Other authors of the study include: Joshua J. Joseph of the Ohio State University College of Medicine in Columbus, Ohio and Felicia Hill-Briggs of the Johns Hopkins University School of Medicine.

The manuscript received no external funding.

The manuscript, "Casting a Health Equity Lens on Endocrinology and Diabetes," was published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to